Long-term experience with surgical treatment of selected patients with bladder pain syndrome/interstitial cystitis

被引:38
|
作者
Andersen, Aage Valdemar [1 ,2 ]
Granlund, Petter [1 ,3 ]
Schultz, Alexander [1 ]
Talseth, Trygve [1 ]
Hedlund, Hans [1 ]
Frich, Lars [1 ]
机构
[1] Oslo Univ Hosp, Dept Urol, Rikshosp, NO-0424 Oslo, Norway
[2] Sorlandet Hosp, Dept Urol, Arendal, Norway
[3] Cent Hosp Karlstad, Urol Sect, Dept Surg, Karlstad, Sweden
来源
关键词
bladder pain syndrome; cystectomy; interstitial cystitis; INTRACTABLE INTERSTITIAL CYSTITIS; INSTITUTES-OF-HEALTH; SUPRATRIGONAL CYSTECTOMY; SUBSTITUTION CYSTOPLASTY; DIAGNOSTIC-CRITERIA; PELVIC PAIN; EPIDEMIOLOGY; MANAGEMENT;
D O I
10.3109/00365599.2012.669789
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective. The role of major surgery in patients with bladder pain syndrome/interstitial cystitis (BPS/IC) is not fully established. This report presents a single-institution experience with major surgery in patients with disabling BPS/IC where conservative treatment had failed. Material and methods. Forty-one patients (34 women, seven men) with BPS/IC refractory to conservative treatment underwent major surgery from 1983 to 2004. Surgical approach was determined on a case-by-case basis. Postoperative pain and satisfaction were assessed by a questionnaire. Results. Cystectomy was the primary procedure in five patients. The remaining 36 patients were primarily operated on with subtotal cystectomy and bladder augmentation (n = 16) or supravesical urinary diversion with intact bladder (n = 20). Thirteen of these patients were later operated on with cystectomy due to persisting pain 12 (6-146) months after the primary procedure. The questionnaire was answered by 38 of 41 patients after a median follow-up of 66 (6-238) months. In total, 28 patients (74%) were free of pain, and 26 patients (68%) were satisfied with the end result. There was no difference in reported pain between cystectomized and non-cystectomized patients. When comparing patients who reported pain at follow-up with those who did not report pain, preoperative length of symptoms was significantly increased, with 12.1 compared to 5.4 years (p = 0.02). Conclusions. Major surgery is associated with good symptom relief in strictly selected patients with disabling BPS/IC, where conservative treatment has failed. Extended preoperative duration of symptoms may be a predictor for persisting pain after major surgery for BPS/IC.
引用
收藏
页码:284 / 289
页数:6
相关论文
共 50 条
  • [21] Interstitial cystitis, bladder pain syndrome, hypersensitive bladder, and interstitial cystitis/bladder pain syndrome - clarification of definitions and relationships
    Homma, Yukio
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 20 - 24
  • [22] Interstitial cystitis or "bladder pain syndrome"?
    Roth, Stephan
    AKTUELLE UROLOGIE, 2008, 39 (03)
  • [23] Interstitial Cystitis/Bladder Pain Syndrome
    Marcu, Ioana
    Campian, E. Cristian
    Tu, Frank F.
    SEMINARS IN REPRODUCTIVE MEDICINE, 2018, 36 (02) : 123 - 135
  • [24] Interventional Pain Management in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome
    Kalajian, Tyler
    Drerup, Brenden
    Drerup, Jennifer
    Burke, Martin
    Selassie, Meron
    CURRENT BLADDER DYSFUNCTION REPORTS, 2025, 20 (01) : 9 - 9
  • [25] Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome
    Lim, Yik N.
    Dwyer, Peter
    Murray, Christine
    Karmakar, Debjyoti
    Rosamilia, Anna
    Thomas, Elizabeth
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2017, 28 (07) : 1085 - 1089
  • [26] Long term outcomes of cystectomy with bladder substitution in the treatment of advanced interstitial cystitis/bladder pain syndrome: A retrospective cohort series
    Dhar, Nivedita
    Moore, Courtenay K.
    Bhatt, Amit
    Hernandez, Adrian V.
    Zippe, Craig D.
    Vasavada, Sandip
    Rackley, Raymond R.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 246 - 247
  • [27] Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome
    Yik N. Lim
    Peter Dwyer
    Christine Murray
    Debjyoti Karmakar
    Anna Rosamilia
    Elizabeth Thomas
    International Urogynecology Journal, 2017, 28 : 1085 - 1089
  • [28] AMNIOTIC BLADDER THERAPY IN PATIENTS WITH INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME
    Madan, Raghav
    Radoiu, Codrut
    Vercnocke, Jack
    Liaw, Aron
    Lucas, Steven
    Hamada, Alaa
    Dhar, Nivedita
    JOURNAL OF UROLOGY, 2024, 211 (05): : E537 - E538
  • [29] Voiding dysfunctions in patients with non-Hunner's ulcer interstitial cystitis/bladder pain syndrome do not affect long-term treatment outcome
    Yu, Wan-Ru
    Chang, Wei-Chuan
    Kuo, Hann-Chorng
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (09)
  • [30] Using urinary biomarkers and machine learning models to develop predictive factors for long-term treatment outcome in the patients with interstitial cystitis/bladder pain syndrome
    Jhang, J-F.
    Jiang, Y-H.
    Yu, W-R.
    Chang, T-L.
    Liu, M-C.
    Yang, C-C.
    Kuo, H-C.
    EUROPEAN UROLOGY, 2024, 85 : S1207 - S1209